GWLIX | RNWBX | GWLIX / RNWBX | |
Total Expense Ratio | 0.90 | 1.67 | 54% |
Annual Report Gross Expense Ratio | 1.45 | 1.67 | 87% |
Fund Existence | 21 years | 23 years | - |
Gain YTD | 1.668 | 5.710 | 29% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 146M | 63.8B | 0% |
Annual Yield % from dividends | 0.58 | 0.14 | 407% |
Returns for 1 year | -0.25 | 2.53 | -10% |
Returns for 3 years | -4.17 | 23.98 | -17% |
Returns for 5 years | 6.51 | 32.71 | 20% |
Returns for 10 years | -2.93 | 44.25 | -7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DRLAX | 8.54 | 0.06 | +0.71% |
BNY Mellon Developed Markets RE Scs - A | |||
VTCIX | 144.90 | -0.08 | -0.06% |
Vanguard Tax-Managed Capital App I | |||
MASKX | 22.23 | -0.04 | -0.18% |
iShares Russell 2000 Small-Cap Idx Instl | |||
AHSZX | 18.63 | -0.05 | -0.27% |
Alger Health Sciences Z | |||
RYTFX | 7.19 | -0.02 | -0.28% |
Royce Small-Cap Total Return Svc |